Business

CSL inks $313m deal to bring ‘next-generation’ flu, COVID vaccines to Australia

The deal will give CSL the exclusive licence to US company Arcturus Therapeutics’ technology in the fields of influenza, COVID-19 and other respiratory diseases.

Business / Companies

Brisbane Times – Business

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *

More in:Business